Stocklytics Platform
Asset logo for symbol ORIC
ORIC Pharmaceuticals
ORIC54
$6.32arrow_drop_up5.04%$0.29
Asset logo for symbol ORIC
ORIC54

$6.32

arrow_drop_up5.04%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

ORIC Pharmaceuticals (ORIC) Stocklytics Forecast

ORIC Pharmaceuticals Inc (ORIC) is a biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of cancer. With a strong pipeline and a promising future, ORIC stock is generating significant interest among investors.
Looking ahead, there are several factors that could drive the stock price of ORIC Pharmaceuticals Inc. One such factor is the company's robust clinical program. ORIC has multiple drug candidates in various stages of development, targeting different types of cancer. The progress and success of these clinical trials will play a crucial role in determining the future of ORIC stock.
add ORIC Pharmaceuticals  to watchlist

Keep an eye on ORIC Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for ORIC Pharmaceuticals (ORIC) stock?

Analysts have set a target price of $20.67 for ORIC Pharmaceuticals (ORIC), based on forecasts from 18 analysts. The predicted price range extends from a high of $54 to a low of $8. This represents a potential increase of up to 754.16% and a decrease of 26.54% from the current price of $6.32. These forecasts are as of 2020 May 19.
help

What are the analyst ratings for ORIC Pharmaceuticals (ORIC) stock?

The analyst ratings for ORIC Pharmaceuticals (ORIC) are distributed as follows: 11 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering ORIC Pharmaceuticals .
help

What is the AI price prediction for ORIC Pharmaceuticals (ORIC) stock?

At present, there is no AI or machine-learning-based price prediction available for ORIC Pharmaceuticals (ORIC) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level